Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Strategic Alliance signed with Nexscient Inc

10th Nov 2025 07:00

RNS Number : 7696G
Tekcapital plc
10 November 2025
 

 

 

10 November 2025

Tekcapital plc

("Tekcapital", the "Company" or the "Group")

  Nexscient and Tekcapital sign a Strategic Alliance to Accelerate GenAI-Driven Technology Acquisitions

 

Tekcapital plc (AIM: TEK), the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people's lives, is pleased to announce it has entered into a strategic alliance with Nexscient, Inc. (OTCQB: NXNT), an innovator in artificial intelligence ("AI") applications and intelligent enterprise solutions, to identify and help acquire transformative intellectual property assets for Nexscient from research institutions worldwide.

 

Under the alliance, Tekcapital will leverage its extensive university and technology network to identify and facilitate Technology Acquisition Opportunities that align with Nexscient's AI and advanced computing focus areas. Nexscient will evaluate and pursue acquisitions or licenses of these innovations through strategic transactions aimed at creating long-term shareholder value.

 

Fred E. Tannous, Chief Executive Officer of Nexscient, Inc. said:

"This alliance with Tekcapital represents a powerful extension of Nexscient's vision to identify, fund, and commercialize high-impact AI technologies. Tekcapital's unparalleled access to global university innovation, combined with our ability to integrate and scale those technologies into commercial AI solutions, creates a dynamic pathway from academic discovery to market transformation. We believe that this collaboration accelerates our mission to deliver the next dimension of AI."

 

Under the terms of the agreement, Tekcapital will provide Nexscient with continuous access to a curated pipeline of university-originated technologies that meet Nexscient's acquisition profile. Tekcapital will identify technology acquisition candidates, lead early-stage negotiations, and where appropriate, structure initial transactions for technologies that Nexscient may acquire using Nexscient stock as consideration.

 

Dr. Clifford M. Gross, Executive Chairman of Tekcapital, commented:

"We're delighted to enter this alliance with Nexscient and its visionary leadership team. By linking Tekcapital's global innovation sourcing capabilities with Nexscient's executional strength, we are enabling a fast-track mechanism for converting GenAI research breakthroughs into value-generating enterprises. We believe this is precisely the kind of collaboration that helps to bridge the gap between invention and implementation."

 

Both organizations have agreed to update the market when significant milestones are achieved under this alliance.

 

For further information, please contact: 

Tekcapital plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)

Abigail Wayne / Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

 

About Nexscient, Inc.

Nexscient® [OTCQB: NXNT] is an emerging-growth AI company that leverages its technical expertise, business acumen, and capital resources to identify, fund, integrate, and commercialize AI and machine learning technologies. Through its subsidiaries and strategic alliances, Nexscient is building a diversified portfolio of intelligent solutions across multiple industries, including predictive maintenance, data annotation, and industrial automation. For more information, please visit https://nexscient.ai/.

 

About Tekcapital plc

Tekcapital® creates value from investing in new, university-developed discoveries that can enhance people's lives. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

LEI: 213800GOJTOV19FIFZ85

Forward-Looking Statements

This release contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Nexscient, Inc., its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy; and (iv) performance of our products and services. You can identify these statements by the use of the words "may," "will," "could," "should," "would," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," "likely," "forecast," "probable," "potential," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Nexscient's ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. These risks and uncertainties also include such additional risk factors as are discussed in the Company's filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2025, Forms 10-Q and 8-K, and in other filings we make with the Securities and Exchange Commission from time to time. These documents are available on the SEC Filings section of the Investor Relations section of our website at https://nexscient.ai. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUPGBWGUPAGWB

Related Shares:

TekCapital
FTSE 100 Latest
Value9,864.33
Change77.18